ByHeart Expands Infant Formula Recall Nationwide as Investigation Continues
WEDNESDAY, Nov. 12, 2025 ByHeart Inc. has announced a full recall of all its Whole Nutrition Infant Formula products due to concerns about potential contaminati
With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
The planned trial targets adults with Stage 2-4 chronic kidney disease and will track kidney function and inflammation markers. Recruitment starts after listing. Post Views: 1